Connect with us

Healthcare

NYC Health Commissioner Resigns Over Mayor de Blasio’s Covid-19 Failures

Published

on

NYC Mayor Bill de Blasio

Fox News is reporting that New York City Health Commissioner Dr. Oxiris Barbot resigned abruptly from her post Tuesday. She said her resignation was due to Mayor Bill de Blasio’s handling of the novel coronavirus pandemic.

Barbot listed her concerns and reasons for resigning in a highly critical letter.

The story was first reported in the New York Times, which first obtained the letter to de Blasio in which she states: “I leave my post today with deep disappointment that during the most critical public health crisis in our lifetime, that the Health Department’s incomparable disease control expertise was not used to the degree it could have been.” 

“Our experts are world renowned for their epidemiology, surveillance and response work,” Barbot added. “The city would be well served by having them at the strategic center of the response not in the background.”

For more on this story go to Fox News.

You may like

Continue Reading

Healthcare

TN Republican introduces legislation to fight opioid shipments into U.S.

Published

on

Fentanyl 1031234188 scaled

Tennessee Republican Representative Diana Harshbarger is attempting to fight the opioid crisis and epidemic through new legislation. Introduced Friday, Harshbarger told the Daily Caller:

The Daily Caller first obtained a copy of the legislation, which addresses what Harshbarger calls a “loophole.” The legislation amends the Controlled Substances Act to specifically require registrants to investigate reports of suspicious orders of controlled substances and halt them if necessary. Under the version of the act currently in force, drug manufacturers and distributors are only required to report suspicious orders of opioids and other controlled substances to the DEA.

“Breaking the opioid epidemic’s stranglehold on our nation is one of my foremost priorities. In an effort to do so, my colleagues and I have identified a loophole that allows distributors to continue order fulfillment, even under suspicious circumstances.”

“My bill closes that loophole with the requirements and guardrails needed to ensure these addictive and potentially dangerous drugs do not fall into the wrong hands while the DEA investigates. The future of our nation depends on us solving the addiction crisis, and this is a step towards that outcome” Harshbarger continued.

The Daily Caller reports:

According to a congressional report released in September, the opioid crisis cost the U.S. $1.5 trillion during the COVID-19 pandemic.

The CDC says 93,331 people died from overdoses in the U.S. in 2020, the highest in 50 years. Opioid-related deaths made up nearly three-quarters of the total.

Pharmaceutical companies have been blamed for contributing to the opioid epidemic. The Department of Justice is currently suing the pharmaceutical company AmerisourceBergen over allegations the company failed to report suspicious orders of opioids to federal law enforcement.

You may like

Continue Reading
Advertisement
-->

Trending Now

Advertisement
-->

Trending

Proudly Made In America | © 2022 M3 Media Management, LLC